Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
| Actual shortage: | 246 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MEDROXY | 10MG | TABLET | Resolved | 2020-09-09 | 2020-12-07 | 123944 |
| APO-MEDROXY | 10MG | TABLET | Resolved | 2021-05-28 | 2021-08-03 | 140069 |
| APO-MEDROXY | 100MG | TABLET | Resolved | 2021-08-27 | 2022-01-31 | 144662 |
| APO-MEDROXY | 10MG | TABLET | Resolved | 2021-10-15 | 2022-01-31 | 147302 |
| APO-MEDROXY | 10MG | TABLET | Resolved | 2022-07-22 | 2022-08-12 | 165326 |
| APO-MEDROXY | 10MG | TABLET | Resolved | 2023-01-13 | 2024-03-22 | 181101 |
| APO-MEDROXY | 100MG | TABLET | Resolved | 2023-04-14 | 2024-03-22 | 189671 |
| APO-MEDROXY | 10MG | TABLET | Resolved | 2023-09-01 | 2023-12-22 | 203557 |
| APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2017-06-28 | 2017-10-26 | 14183 |
| APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2018-07-04 | 2018-08-22 | 54184 |
| APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2018-08-27 | 2021-12-10 | 59299 |
| APO-MEDROXY TABLETS | 5MG | TABLET | Resolved | 2021-10-01 | 2022-01-31 | 146508 |
| APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2021-10-15 | 2022-01-31 | 147299 |
| APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2023-04-14 | 2024-03-22 | 189662 |
| APO-MEDROXY TABLETS | 5MG | TABLET | Resolved | 2023-04-14 | 2024-03-22 | 189665 |
| APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2023-09-07 | 2023-12-01 | 203822 |
| APO-MEDROXY TABLETS | 5MG | TABLET | Resolved | 2023-09-15 | 2023-12-01 | 204414 |
| APO-MELOXICAM | 15MG | TABLET | Resolved | 2017-03-10 | 2017-07-13 | 378 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2017-03-11 | 2019-11-25 | 586 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2017-03-11 | 2018-05-02 | 589 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
| APO-SULIN TAB 200MG | 200MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1172 |
| APO-TADALAFIL | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-02-13 | 61045 |
| APO-TAMOX TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-09-12 | 61050 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71345 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |
| APO-TERAZOSIN | 5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4749 |
| APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 |